Trial intelligence / Profile preview

Carboxytherapy and Intralesional Steroids for Alopecia Areata

NCT04228029Phase 4Unknown

Sponsor
Kasr Al Ainy Hospital
Start
Aug 2019
Primary completion
Feb 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of triamcinolone acetonide in alopecia areata, sponsored by Kasr Al Ainy Hospital. Status: unknown.

02

Drugs

triamcinolone acetonide
03

Conditions

alopecia areata

Beyond the preview

Go deeper on NCT04228029.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04228029.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call